Stuart A. Arbuckle - 14 Feb 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, COO
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
14 Feb 2023
Net transactions value
-$1,910,962
Form type
4
Filing time
16 Feb 2023, 15:14:12 UTC
Previous filing
14 Feb 2023
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale $236,672 -800 -0.98% $295.84 81,203 14 Feb 2023 Direct F1, F2, F3
transaction VRTX Common Stock Sale $267,462 -901 -1.1% $296.85 80,302 14 Feb 2023 Direct F1, F2, F4
transaction VRTX Common Stock Sale $166,958 -560 -0.7% $298.14 79,742 14 Feb 2023 Direct F1, F2, F5
transaction VRTX Common Stock Sale $599,157 -2,003 -2.5% $299.13 77,739 14 Feb 2023 Direct F1, F2, F6
transaction VRTX Common Stock Sale $520,356 -1,734 -2.2% $300.09 76,005 14 Feb 2023 Direct F1, F2, F7
transaction VRTX Common Stock Sale $120,356 -400 -0.53% $300.89 75,605 14 Feb 2023 Direct F1, F2, F8
holding VRTX Common Stock 140 14 Feb 2023 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
F2 Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $295.84 (range $295.34 to $296.20).
F4 Open market sales reported on this line occurred at a weighted average price of $296.85 (range $296.49 to $297.30).
F5 Open market sales reported on this line occurred at a weighted average price of $298.14 (range $297.59 to $298.57).
F6 Open market sales reported on this line occurred at a weighted average price of $299.13 (range $298.68 to $299.60).
F7 Open market sales reported on this line occurred at a weighted average price of $300.09 (range $299.73 to $300.70).
F8 Open market sales reported on this line occurred at a weighted average price of $300.89 (range $300.78 to $301.03).